RecruitingPhase 1 / Phase 2NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Sponsor: Eikon Therapeutics
Doral, FL · Hialeah, FL · Plantation, FL · +7 more sites